In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery
► Synthesis and characterization of novel amphiphilic chitosan derivates as drug delivery system. ► Introduction of phthalyl groups could lower CMC and improve solubility in aqueous and organic system. ► Drug-loaded micelles with small particle size, narrow distribution and high drug loading efficie...
Saved in:
Published in | Carbohydrate polymers Vol. 92; no. 1; pp. 545 - 554 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
30.01.2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Synthesis and characterization of novel amphiphilic chitosan derivates as drug delivery system. ► Introduction of phthalyl groups could lower CMC and improve solubility in aqueous and organic system. ► Drug-loaded micelles with small particle size, narrow distribution and high drug loading efficiency. ► Enhancement on cellular uptake by active tumor targeting. ► Mechanism of cellular uptake varied from different surface properties.
In this study, a novel amphiphilic copolymer designed as N-octyl-N-phthalyl-3,6-O-(2-hydroxypropyl) chitosan (OPHPC) were synthesized and then conjugated with folic acid (FA-OPHPC) to produce a targeted drug carrier for tumor-specific drug delivery. OPHPC and FA-OPHPC were characterized by FT-IR, 1H NMR, 13C NMR and elemental analysis. Paclitaxel (PTX) loaded OPHPC micelles (PTX-OPHPC) with well-defined spherical shape and homogeneous distribution exhibited drug-loading rate ranging from 33.6% to 45.3% and entrapment efficiency from 50.5% to 82.8%. In the cellular uptake studies, PTX-OPHPC brought about a significantly higher amount of PTX accumulated in human breast adenocarcinoma cell line (MCF-7 cells) compared with Taxol®. Moreover, the cellular uptake of PTX in PTX loaded FA-OPHPC micelles (PTX-FA-OPHPC) was 3.2-fold improved in comparison with that of PTX-OPHPC. The results revealed that OPHPC micelle might be a promising drug carrier for promoting PTX cellular uptake and FA-OPHPC micelle could be used as a potential tumor-targeted drug vector. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.carbpol.2012.08.112 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0144-8617 1879-1344 1879-1344 |
DOI: | 10.1016/j.carbpol.2012.08.112 |